Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Oculus Innovative Sciences Strengthens Intellectual Property Portfolio With Issuance of U.S. Patent for Prevention and Treatment of Peritonitis With Microcyn(R) Technology
Oculus Innovative Sciences Strengthens Intellectual Property Portfolio With Issuance of U.S. Patent for Prevention and Treatment of Peritonitis With Microcyn(R) Technology
Oculus Innovative Sciences Strengthens Intellectual Property Portfolio With Issuance of U.S. Patent for Prevention and Treatment of Peritonitis With Microcyn(R) Technology
Submitted by
moderatorj
on September 11, 2012 - 10:39pm
Source:
Yahoo/GlobeNewswire
News Tags:
Oculus Innovative Sciences
US
patent
treatment
Microcyn
Headline:
Oculus Innovative Sciences Strengthens Intellectual Property Portfolio With Issuance of U.S. Patent for Prevention and Treatment of Peritonitis With Microcyn(R) Technology
Do Not Allow Advertisers to Use My Personal information
